Cargando…
Antibody therapies for the treatment of COVID-19
An outbreak of COVID-19, the disease caused by infection of the coronavirus SARS-CoV-2, that began in December 2019 in Wuhan, China has caused more than 2,990,559 confirmed human infections and 207,446 deaths as of April 27, 2020 (Coronavirus COVID-19 Global Cases by the Center for Systems Science a...
Autores principales: | Ku, Zhiqiang, Ye, Xiaohua, Toa Salazar, Georgina, Zhang, Ningyan, An, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197606/ http://dx.doi.org/10.1093/abt/tbaa007 |
Ejemplares similares
-
T-cell receptor mimic (TCRm) antibody therapeutics against intracellular proteins
por: Xu, Yixiang, et al.
Publicado: (2019) -
Antibody therapies for the prevention and treatment of viral infections
por: Salazar, Georgina, et al.
Publicado: (2017) -
The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective
por: Rios, Adan, et al.
Publicado: (2019) -
Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer
por: Zhang, Shu, et al.
Publicado: (2016) -
Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapy
por: Jordan, Robert E., et al.
Publicado: (2018)